These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29315899)

  • 1. Expanded neurochemical profile in the early stage of Huntington disease using proton magnetic resonance spectroscopy.
    Adanyeguh IM; Monin ML; Rinaldi D; Freeman L; Durr A; Lehéricy S; Henry PG; Mochel F
    NMR Biomed; 2018 Mar; 31(3):. PubMed ID: 29315899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A whole brain longitudinal study in the YAC128 mouse model of Huntington's disease shows distinct trajectories of neurochemical, structural connectivity and volumetric changes.
    Petrella LI; Castelhano JM; Ribeiro M; Sereno JV; Gonçalves SI; Laço MN; Hayden MR; Rego AC; Castelo-Branco M
    Hum Mol Genet; 2018 Jun; 27(12):2125-2137. PubMed ID: 29668904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical correlates of synapse density in a Huntington's disease mouse model.
    Zarate N; Gundry K; Yu D; Casby J; Eberly LE; Öz G; Gomez-Pastor R
    J Neurochem; 2023 Jan; 164(2):226-241. PubMed ID: 36272099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
    Russell DS; Barret O; Jennings DL; Friedman JH; Tamagnan GD; Thomae D; Alagille D; Morley TJ; Papin C; Papapetropoulos S; Waterhouse RN; Seibyl JP; Marek KL
    JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy.
    Tkac I; Dubinsky JM; Keene CD; Gruetter R; Low WC
    J Neurochem; 2007 Mar; 100(5):1397-406. PubMed ID: 17217418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triheptanoin improves brain energy metabolism in patients with Huntington disease.
    Adanyeguh IM; Rinaldi D; Henry PG; Caillet S; Valabregue R; Durr A; Mochel F
    Neurology; 2015 Feb; 84(5):490-5. PubMed ID: 25568297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical correlates of caudate atrophy in Huntington's disease.
    Padowski JM; Weaver KE; Richards TL; Laurino MY; Samii A; Aylward EH; Conley KE
    Mov Disord; 2014 Mar; 29(3):327-35. PubMed ID: 24442623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease.
    Sturrock A; Laule C; Decolongon J; Dar Santos R; Coleman AJ; Creighton S; Bechtel N; Reilmann R; Hayden MR; Tabrizi SJ; Mackay AL; Leavitt BR
    Neurology; 2010 Nov; 75(19):1702-10. PubMed ID: 21060093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral Cortex.
    Häggkvist J; Tóth M; Tari L; Varnäs K; Svedberg M; Forsberg A; Nag S; Dominguez C; Munoz-Sanjuan I; Bard J; Wityak J; Varrone A; Halldin C; Mrzljak L
    J Nucl Med; 2017 Apr; 58(4):617-622. PubMed ID: 27856625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.
    Adanyeguh IM; Henry PG; Nguyen TM; Rinaldi D; Jauffret C; Valabregue R; Emir UE; Deelchand DK; Brice A; Eberly LE; Öz G; Durr A; Mochel F
    Mov Disord; 2015 Apr; 30(5):662-70. PubMed ID: 25773989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson's Disease.
    Pesch B; Casjens S; Woitalla D; Dharmadhikari S; Edmondson DA; Zella MAS; Lehnert M; Lotz A; Herrmann L; Muhlack S; Kraus P; Yeh CL; Glaubitz B; Schmidt-Wilcke T; Gold R; van Thriel C; Brüning T; Tönges L; Dydak U
    Cells; 2019 Jan; 8(2):. PubMed ID: 30699914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatine supplementation lowers brain glutamate levels in Huntington's disease.
    Bender A; Auer DP; Merl T; Reilmann R; Saemann P; Yassouridis A; Bender J; Weindl A; Dose M; Gasser T; Klopstock T
    J Neurol; 2005 Jan; 252(1):36-41. PubMed ID: 15672208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABA and Glutamate in Children with Primary Complex Motor Stereotypies: An 1H-MRS Study at 7T.
    Harris AD; Singer HS; Horska A; Kline T; Ryan M; Edden RA; Mahone EM
    AJNR Am J Neuroradiol; 2016 Mar; 37(3):552-7. PubMed ID: 26542237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical correlation of striatal 1H MRS changes in Huntington's disease.
    Sánchez-Pernaute R; García-Segura JM; del Barrio Alba A; Viaño J; de Yébenes JG
    Neurology; 1999 Sep; 53(4):806-12. PubMed ID: 10489045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of metabolite changes in response to a varying visual stimulation paradigm using short-TE
    Mekle R; Kühn S; Pfeiffer H; Aydin S; Schubert F; Ittermann B
    NMR Biomed; 2017 Feb; 30(2):. PubMed ID: 28008663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease.
    Reynolds NC; Prost RW; Mark LP
    Brain Res; 2005 Jan; 1031(1):82-9. PubMed ID: 15621015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal metabolite changes in Huntington's disease during disease onset.
    van den Bogaard SJ; Dumas EM; Teeuwisse WM; Kan HE; Webb A; van Buchem MA; Roos RA; van der Grond J
    J Huntingtons Dis; 2014; 3(4):377-86. PubMed ID: 25575959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical changes in the progression of Huntington's disease: A meta-analysis of in vivo
    Jing Y; Dogan I; Reetz K; Romanzetti S
    Neurobiol Dis; 2024 Sep; 199():106574. PubMed ID: 38914172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism.
    van den Bogaard SJ; Dumas EM; Teeuwisse WM; Kan HE; Webb A; Roos RA; van der Grond J
    J Neurol; 2011 Dec; 258(12):2230-9. PubMed ID: 21614431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementarity of gluCEST and
    Pépin J; de Longprez L; Trovero F; Brouillet E; Valette J; Flament J
    NMR Biomed; 2020 Jul; 33(7):e4301. PubMed ID: 32198958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.